Ivacaftor (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ivacaftor" in Portuguese language version.

Last modified: 12:27:07, 16 June 2026 (UTC)

Ref.Un. Ref.Website

Global rank Portuguese rank

44nih.gov

5^th place

6^th place

33doi.org

2^nd place

4^th place

22nejm.org

2,717^th place

3,028^th place

22worldcat.org

4^th place

5^th place

11elsevier.com

365^th place

286^th place

11drugbank.com

7,932^nd place

low place

doi.org (Global: 2^nd place; Portuguese: 4^th place)

dx.doi.org

Ramsey, Bonnie W.; Davies, Jane; McElvaney, N. Gerard; Tullis, Elizabeth; Bell, Scott C.; Dřevínek, Pavel; Griese, Matthias; McKone, Edward F.; Wainwright, Claire E.; Konstan, Michael W.; Moss, Richard; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Rowe, Steven M.; Dong, Qunming (3 de novembro de 2011). «A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation». New England Journal of Medicine. 365 (18): 1663–1672. ISSN 0028-4793. PMC 3230303. PMID 22047557. doi:10.1056/NEJMoa1105185
Middleton, Peter G.; Mall, Marcus A.; Dřevínek, Pavel; Lands, Larry C.; McKone, Edward F.; Polineni, Deepika; Ramsey, Bonnie W.; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Vermeulen, François; Marigowda, Gautham; McKee, Charlotte M.; Moskowitz, Samuel M.; Nair, Nitin; Savage, Jessica (7 de novembro de 2019). «Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele». New England Journal of Medicine (em inglês). 381 (19): 1809–1819. ISSN 0028-4793. PMC 7282384. PMID 31697873. doi:10.1056/NEJMoa1908639
Heijerman, Harry G M; McKone, Edward F; Downey, Damian G; Van Braeckel, Eva; Rowe, Steven M; Tullis, Elizabeth; Mall, Marcus A; Welter, John J; Ramsey, Bonnie W; McKee, Charlotte M; Marigowda, Gautham; Moskowitz, Samuel M; Waltz, David; Sosnay, Patrick R; Simard, Christopher (novembro de 2019). «Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial». The Lancet (em inglês). 394 (10212): 1940–1948. PMC 7571408. PMID 31679946. doi:10.1016/S0140-6736(19)32597-8

drugbank.com (Global: 7,932^nd place; Portuguese: low place)

go.drugbank.com

«Ivacaftor». go.drugbank.com (em inglês). Consultado em 16 de junho de 2026

elsevier.com (Global: 365^th place; Portuguese: 286^th place)

linkinghub.elsevier.com

Heijerman, Harry G M; McKone, Edward F; Downey, Damian G; Van Braeckel, Eva; Rowe, Steven M; Tullis, Elizabeth; Mall, Marcus A; Welter, John J; Ramsey, Bonnie W; McKee, Charlotte M; Marigowda, Gautham; Moskowitz, Samuel M; Waltz, David; Sosnay, Patrick R; Simard, Christopher (novembro de 2019). «Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial». The Lancet (em inglês). 394 (10212): 1940–1948. PMC 7571408. PMID 31679946. doi:10.1016/S0140-6736(19)32597-8

nejm.org (Global: 2,717^th place; Portuguese: 3,028^th place)

Ramsey, Bonnie W.; Davies, Jane; McElvaney, N. Gerard; Tullis, Elizabeth; Bell, Scott C.; Dřevínek, Pavel; Griese, Matthias; McKone, Edward F.; Wainwright, Claire E.; Konstan, Michael W.; Moss, Richard; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Rowe, Steven M.; Dong, Qunming (3 de novembro de 2011). «A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation». New England Journal of Medicine. 365 (18): 1663–1672. ISSN 0028-4793. PMC 3230303. PMID 22047557. doi:10.1056/NEJMoa1105185
Middleton, Peter G.; Mall, Marcus A.; Dřevínek, Pavel; Lands, Larry C.; McKone, Edward F.; Polineni, Deepika; Ramsey, Bonnie W.; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Vermeulen, François; Marigowda, Gautham; McKee, Charlotte M.; Moskowitz, Samuel M.; Nair, Nitin; Savage, Jessica (7 de novembro de 2019). «Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele». New England Journal of Medicine (em inglês). 381 (19): 1809–1819. ISSN 0028-4793. PMC 7282384. PMID 31697873. doi:10.1056/NEJMoa1908639

nih.gov (Global: 5^th place; Portuguese: 6^th place)

ncbi.nlm.nih.gov

Ramsey, Bonnie W.; Davies, Jane; McElvaney, N. Gerard; Tullis, Elizabeth; Bell, Scott C.; Dřevínek, Pavel; Griese, Matthias; McKone, Edward F.; Wainwright, Claire E.; Konstan, Michael W.; Moss, Richard; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Rowe, Steven M.; Dong, Qunming (3 de novembro de 2011). «A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation». New England Journal of Medicine. 365 (18): 1663–1672. ISSN 0028-4793. PMC 3230303. PMID 22047557. doi:10.1056/NEJMoa1105185
Middleton, Peter G.; Mall, Marcus A.; Dřevínek, Pavel; Lands, Larry C.; McKone, Edward F.; Polineni, Deepika; Ramsey, Bonnie W.; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Vermeulen, François; Marigowda, Gautham; McKee, Charlotte M.; Moskowitz, Samuel M.; Nair, Nitin; Savage, Jessica (7 de novembro de 2019). «Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele». New England Journal of Medicine (em inglês). 381 (19): 1809–1819. ISSN 0028-4793. PMC 7282384. PMID 31697873. doi:10.1056/NEJMoa1908639
Heijerman, Harry G M; McKone, Edward F; Downey, Damian G; Van Braeckel, Eva; Rowe, Steven M; Tullis, Elizabeth; Mall, Marcus A; Welter, John J; Ramsey, Bonnie W; McKee, Charlotte M; Marigowda, Gautham; Moskowitz, Samuel M; Waltz, David; Sosnay, Patrick R; Simard, Christopher (novembro de 2019). «Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial». The Lancet (em inglês). 394 (10212): 1940–1948. PMC 7571408. PMID 31679946. doi:10.1016/S0140-6736(19)32597-8
Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis. Col: National Institute for Health and Care Excellence: Technology Appraisals. London: National Institute for Health and Care Excellence (NICE). 2024. ISBN 978-1-4731-6249-5. PMID 39965067. Consultado em 16 de junho de 2026

worldcat.org (Global: 4^th place; Portuguese: 5^th place)

Ramsey, Bonnie W.; Davies, Jane; McElvaney, N. Gerard; Tullis, Elizabeth; Bell, Scott C.; Dřevínek, Pavel; Griese, Matthias; McKone, Edward F.; Wainwright, Claire E.; Konstan, Michael W.; Moss, Richard; Ratjen, Felix; Sermet-Gaudelus, Isabelle; Rowe, Steven M.; Dong, Qunming (3 de novembro de 2011). «A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation». New England Journal of Medicine. 365 (18): 1663–1672. ISSN 0028-4793. PMC 3230303. PMID 22047557. doi:10.1056/NEJMoa1105185
Middleton, Peter G.; Mall, Marcus A.; Dřevínek, Pavel; Lands, Larry C.; McKone, Edward F.; Polineni, Deepika; Ramsey, Bonnie W.; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Vermeulen, François; Marigowda, Gautham; McKee, Charlotte M.; Moskowitz, Samuel M.; Nair, Nitin; Savage, Jessica (7 de novembro de 2019). «Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele». New England Journal of Medicine (em inglês). 381 (19): 1809–1819. ISSN 0028-4793. PMC 7282384. PMID 31697873. doi:10.1056/NEJMoa1908639

Ivacaftor (Portuguese Wikipedia)

doi.org (Global: 2nd place; Portuguese: 4th place)

dx.doi.org

drugbank.com (Global: 7,932nd place; Portuguese: low place)

go.drugbank.com

elsevier.com (Global: 365th place; Portuguese: 286th place)